Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07116603) titled 'Prevalence of Urinary Incontinence and Identification of Risk Factors Among Fe... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07116642) titled 'Comparing Patient Reported Outcomes and Clinical Outcomes Based on Different S... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07113652) titled 'The Efficacy of Temporal Interference Stimulation in the Treatment of Obsessiv... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07116434) titled 'Discovery Diabetes' on Aug. 6. Study Type: Interventional Study Design: Al... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07116525) titled 'A Study Assessing Arrhythmia Mapping With a Multi-Electrode Mapping Catheter' ... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07116655) titled 'Feasibility Study of Single-session Solution Focused Consultation to Enhance T... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07119775) titled 'Tideglusib: Expanded Access Use in Congenital Myotonic Dystrophy' on Aug. 6. ... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07119918) titled 'PCSK9 Inhibitor for Intracranial Atherosclerotic Symptomatic Stenosis' on Aug.... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07116447) titled 'Impact of Alcohol Health Messages in a Real-world Online Retail Setting' on Au... Read More
Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07116577) titled 'Radiotherapy Combined QL1706, TAS-102 and Bevacizumab in mCRC' on Aug. 6. Stu... Read More